These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 33140729)
1. [Molecular mechanisms of the cardiotoxic action of anthracycline antibiotics and statin-induced cytoprotective reactions of cardiomyocytes]. Tursunova NV; Klinnikova MG; Babenko OA; Lushnikova EL Biomed Khim; 2020 Sep; 66(5):357-371. PubMed ID: 33140729 [TBL] [Abstract][Full Text] [Related]
2. Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review. Bhasin V; Vakilpour A; Scherrer-Crosbie M Curr Oncol Rep; 2024 Oct; 26(10):1197-1204. PubMed ID: 39002055 [TBL] [Abstract][Full Text] [Related]
3. Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers. Henninger C; Fritz G Cell Death Dis; 2017 Jan; 8(1):e2564. PubMed ID: 28102848 [TBL] [Abstract][Full Text] [Related]
4. Statin Therapy for Prevention of Anthracycline Cardiotoxicity - Another Defeat for Cardioprotection? Divakaran S; Nohria A NEJM Evid; 2022 Sep; 1(9):EVIDe2200166. PubMed ID: 38319795 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Aspects of Anthracycline Cardiotoxicity. Russo M; Della Sala A; Tocchetti CG; Porporato PE; Ghigo A Curr Treat Options Oncol; 2021 Feb; 22(2):18. PubMed ID: 33547494 [TBL] [Abstract][Full Text] [Related]
6. Cardio-protective effects of statins in patients undergoing anthracycline-based chemotherapy: An updated meta-analysis of randomized controlled trials. Felix N; Nogueira PC; Silva IM; Costa TA; Campello CA; Stecca C; Lopes RD Eur J Intern Med; 2024 Aug; 126():43-48. PubMed ID: 38643042 [TBL] [Abstract][Full Text] [Related]
7. Statins for Attenuating Cardiotoxicity in Patients Receiving Anthracyclines: A Systematic Review and Meta-Analysis. Titus A; Cheema HA; Shafiee A; Seighali N; Shahid A; Bhanushali KB; Kumar A; Khan SU; Khadke S; Thavendiranathan P; Hundley WG; Scherrer-Crosbie M; Nohria A; Neilan TG; Dani SS; Nasir K; Ganatra S Curr Probl Cardiol; 2023 Oct; 48(10):101885. PubMed ID: 37336312 [TBL] [Abstract][Full Text] [Related]
8. Anthracycline-induced cardiotoxicity - are we about to clear this hurdle? Dempke WCM; Zielinski R; Winkler C; Silberman S; Reuther S; Priebe W Eur J Cancer; 2023 May; 185():94-104. PubMed ID: 36966697 [TBL] [Abstract][Full Text] [Related]
9. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management. Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628 [TBL] [Abstract][Full Text] [Related]
10. New signal transduction paradigms in anthracycline-induced cardiotoxicity. Ghigo A; Li M; Hirsch E Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients. Stansfeld A; Radia U; Goggin C; Mahalingam P; Benson C; Napolitano A; Jones RL; Rosen SD; Karavasilis V Expert Opin Pharmacother; 2022 Oct; 23(14):1641-1650. PubMed ID: 36102190 [TBL] [Abstract][Full Text] [Related]
12. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity. Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503 [TBL] [Abstract][Full Text] [Related]
13. Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy. Fulbright JM; Egas-Bejar DE; Huh WW; Chandra J Cancer Chemother Pharmacol; 2015 Dec; 76(6):1297-307. PubMed ID: 26515054 [TBL] [Abstract][Full Text] [Related]